Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Voyager Therapeutics, Inc. (VYGR) had Return on Equity of -21.68% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$80.00M |
|
$-65.00M |
|
-- |
|
$80.00M |
|
$163.29M |
|
$-83.29M |
|
$18.95M |
|
$-64.34M |
|
$-64.34M |
|
$-65.00M |
|
$-65.00M |
|
$-65.00M |
|
$-65.00M |
|
$-83.29M |
|
$-86.53M |
|
57.67M |
|
57.67M |
|
$-1.13 |
|
$-1.13 |
|
| Balance Sheet Financials | |
$276.81M |
|
$14.31M |
|
$116.24M |
|
$393.05M |
|
$49.79M |
|
-- |
|
$43.50M |
|
$93.29M |
|
$299.76M |
|
$299.76M |
|
$299.76M |
|
54.73M |
|
| Cash Flow Statement Financials | |
$-15.31M |
|
$-94.86M |
|
$114.02M |
|
$70.39M |
|
$74.24M |
|
$3.85M |
|
$14.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-104.11% |
|
-104.11% |
|
-108.15% |
|
-80.42% |
|
-81.25% |
|
$-18.83M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
-- |
|
36.70 |
|
9.95 |
|
|
Return on Equity |
-21.68% |
-21.68% |
|
-16.54% |
|
-21.68% |
|
$5.48 |
|
$-0.33 |
|
$-0.27 |
|